BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 1324252)

  • 1. Enhanced calcium uptake by CA1 pyramidal cell dendrites in the postischemic phase despite subnormal evoked field potentials: excitatory amino acid receptor dependency and relationship to neuronal damage.
    Andiné P; Jacobson I; Hagberg H
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):773-83. PubMed ID: 1324252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium uptake evoked by electrical stimulation is enhanced postischemically and precedes delayed neuronal death in CA1 of rat hippocampus: involvement of N-methyl-D-aspartate receptors.
    Andiné P; Jacobson I; Hagberg H
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):799-807. PubMed ID: 2848046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postischemic enhancements of N-methyl-D-aspartic acid (NMDA) and non-NMDA receptor-mediated responses in hippocampal CA1 pyramidal neurons.
    Mitani A; Namba S; Ikemune K; Yanase H; Arai T; Kataoka K
    J Cereb Blood Flow Metab; 1998 Oct; 18(10):1088-98. PubMed ID: 9778185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion homeostasis in rat brain in vivo: intra- and extracellular [Ca2+] and [H+] in the hippocampus during recovery from short-term, transient ischemia.
    Silver IA; Erecińska M
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):759-72. PubMed ID: 1324251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression and functionality of NMDA receptor complexes persist in the CA1, but not in the dentate gyrus after transient cerebral ischemia.
    Hsu JC; Zhang Y; Takagi N; Gurd JW; Wallace MC; Zhang L; Eubanks JH
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):768-75. PubMed ID: 9663507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic Ca2+ accumulations and metabotropic glutamate receptor activation associated with an N-methyl-D-aspartate receptor-independent long-term potentiation in hippocampal CA1 neurons.
    Petrozzino JJ; Connor JA
    Hippocampus; 1994 Oct; 4(5):546-58. PubMed ID: 7889125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of adenosine in ischemic and postischemic calcium regulation.
    Andiné P
    Mol Chem Neuropathol; 1993; 18(1-2):35-49. PubMed ID: 8096697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate receptor antagonists are less effective in blocking long-term potentiation at apical than basal dendrites in hippocampal CA1 of awake rats.
    Leung LS; Shen B
    Hippocampus; 1999; 9(6):617-30. PubMed ID: 10641754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus.
    Zhong WX; Dong ZF; Tian M; Cao J; Xu L; Luo JH
    Neuroscience; 2006 Sep; 141(3):1399-413. PubMed ID: 16766131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil.
    Warner MA; Neill KH; Nadler JV; Crain BJ
    J Cereb Blood Flow Metab; 1991 Jul; 11(4):600-10. PubMed ID: 1828809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responses to NMDA receptor activation in rat hippocampal interneurons and pyramidal cells may underlie enhanced pyramidal cell vulnerability.
    Avignone E; Frenguelli BG; Irving AJ
    Eur J Neurosci; 2005 Dec; 22(12):3077-90. PubMed ID: 16367774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular mechanisms underlying the rhythmic bursts induced by NMDA microiontophoresis at the apical dendrites of CA1 pyramidal neurons.
    Bonansco C; Buño W
    Hippocampus; 2003; 13(1):150-63. PubMed ID: 12625465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
    Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
    Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine-dependent stimulus-triggered oscillations in the CA3 region of hippocampal slices from rats chronically exposed to lead.
    He SJ; Xiao C; Wu ZY; Ruan DY
    Exp Neurol; 2004 Dec; 190(2):525-34. PubMed ID: 15530891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow afterhyperpolarization governs the development of NMDA receptor-dependent afterdepolarization in CA1 pyramidal neurons during synaptic stimulation.
    Wu WW; Chan CS; Disterhoft JF
    J Neurophysiol; 2004 Oct; 92(4):2346-56. PubMed ID: 15190096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective blockade of Ca2+ permeable AMPA receptors in CA1 area of rat hippocampus.
    Buldakova SL; Kim KK; Tikhonov DB; Magazanik LG
    Neuroscience; 2007 Jan; 144(1):88-99. PubMed ID: 17097234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.